Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

Clinical Trial Affirms CoviDTH Diagnostic Approach to screen for T cell-mediated immune response to SARS-CoV-2 is safe and effective in humans

Yvelise Barrios, MD, PhD, Immunologist and leading expert in the clinical use of delayed type hypersensitivity ("DTH"), the mechanism behindCoviDTH, joins BioVaxys as scientific adviser VANCOUVER, BC and SAN CRISTÓBAL DE LA LAGUNA, Spain, Aug. 3, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (C...

2021-08-03 20:00 4625

Ng Teng Fong Charitable Foundation will Donate 20 Scholarships with a Value of HK$200,000 Each for the Lucky Draw among Vaccinated Hong Kong Residents Aged 12 or Above and Below 18

HONG KONG, Aug. 3, 2021 /PRNewswire/ -- Encouraging the community to reach a high vaccination rate is an important way to achieve herd immunity, and in turn also enables students to return to school as soon as possible in a safe healthy environment. Everyone has a part to play in contributing to ...

2021-08-03 19:38 6170

23rd China (Guangzhou) International Building Decoration Fair Closes and New Exhibition Announced for 2022

GUANGZHOU, China, Aug. 3, 2021 /PRNewswire/ -- The 23rd China (Guangzhou) International Building Decoration Fair ("CBD Fair 2021" or "the Fair") came to an end onJuly 23, attracting 172,783 professional visitors to the event. The 24th CBD Fa...

2021-08-03 17:00 2752

23rd China (Guangzhou) International Building Decoration Fair Closes and New Exhibition Announced for 2022

Coller Capital And Ping An Overseas Holdings Announce Closure Of One Of The World's Largest Private Credit Secondaries Transaction

HONG KONG and SHANGHAI, Aug. 3, 2021 /PRNewswire/ -- Coller Capital ("Coller") and Ping An Overseas Holdings together with its subsidiaries ("Ping An"), the main offshore investment and asset management platform of Ping An Insurance (Group) Company ofChina, Ltd., have closed one of the world's la...

2021-08-03 16:05 3975

Angel Yeast Reports Strong Revenue Growth in First Half of 2021, Achieves 20.55% YoY Increase

YICHANG, China, Aug. 3, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast ")(en.angelyeast.com ), a listed high-tech yeast company inChina, today announces its first-half fiscal year 2021 financial and business results endingJune 30, 2021. Highlights of the rep...

2021-08-03 15:54 1757

Nanoform and Boehringer Ingelheim execute master services agreement

HELSINKI, Aug. 3, 2021 /PRNewswire/ -- Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies may now be performed for Boehringer Ingelheim to assess the added value Nanoform's award-winning CESS® technology can deliver to its drug development proj...

2021-08-03 14:28 1951

GenScript Joins Forces with Allozymes by Providing Smart Libraries Construction for Precision Protein Engineering

SINGAPORE, Aug. 3, 2021 /PRNewswire/ -- GenScript Biotech Corporation (Stock Code: 1548.HK) today announced a collaboration with Allozymes, a synthetic biology company transforming ingredient manufacturing by unlocking protein engineering potential through groundbreaking technologies. In this par...

2021-08-03 12:05 7715

Jacobio Announces First Patient Dosed in Phase I/II Clinical Trial of KRAS G12C Inhibitor for Solid Tumor

BEIJING, Aug. 3, 2021 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK) today announced the first patient was dosed in a Phase I/II clinical trial of KRAS G12C inhibitor JAB-21822 inChina. JAB-21822 is Jacobio's innovative in-house small molecule anti-cancer drug, which is designed to target t...

2021-08-03 09:00 2660

CStone announces positive registrational study of the first-in-class drug ivosidenib in Chinese patients with relapsed or refractory acute myeloid leukemia, and NDA has been accepted by the China NMPA and considered for Priority Review

* Ivosidenib (TIBSOVO®, the brand name in the U.S.) is the first isocitrate dehydrogenase 1 (IDH1) inhibitor inChina that has demonstrated its efficacy and manageable safety in patients with relapsed or refractory acute myeloid leukemia (R/R AML) * The National Medical Products Administration...

2021-08-03 08:05 3098

Insilico Medicine and Westlake Pharma Announce Cooperation Relationship on Accelerating the Innovative Drugs R&D for Novel Coronavirus

HANGZHOU, China, Aug. 3, 2021 /PRNewswire/ -- Insilico Medicine and Westlake Pharma announced a strategic partnership to jointly develop innovative small-molecule drugs for Novel Coronavirus (COVID-19) today. Insilico Medicin...

2021-08-03 08:00 32825

Insilico Medicine and Westlake Pharma Announce Cooperation Relationship on Accelerating the Innovative Drugs R&D for Novel Coronavirus

Cardinal Health completes sale of Cordis business to Hellman & Friedman

DUBLIN, Ohio, Aug. 2, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously announced sale of Cardinal Health's Cordis business to H&F. The sale price of approximately$1 billion includes the buyer's assumption of certain lia...

2021-08-02 23:00 3156

SI Group Ranks in the Top 5 Percent for Global Corporate Social Responsibility

Company Awarded Gold Rating by EcoVadis for its Sustainability Commitment SCHENECTADY, N.Y., Aug. 2, 2021 /PRNewswire/ -- SI Group, a global leader in the innovative technology of performance additives, process solutions, active pharmaceutical ingredients, and chemical intermediates, has received...

2021-08-02 22:33 2131

SI Group Ranks in the Top 5 Percent for Global Corporate Social Responsibility

Vision Impact Institute Applauds UN Resolution on Vision

Resolution highlights impact of good vision to achieving the Sustainable Development Goals DALLAS, Aug. 2, 2021 /PRNewswire/ -- The Vision Impact Institute applauds the UN General Assembly's adoption of theVision for Everyone: accelerating action to achieve the Sustainable Development Goals reso...

2021-08-02 22:30 1750

WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate

SUZHOU, China, Aug. 2, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that only 13 months after receiving its first GMP certificate, it has once again received a European Medicines Agency (EMA) GMP c...

2021-08-02 20:13 2853

Glenmark inks agreement with Canadian biotech SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets

* Nitric oxide has antimicrobial properties with direct proven effect on SARS-CoV-2 * Nitric Oxide Nasal Spray (NONS) has been tested in healthy volunteers and patients as part of UK andCanada clinical trials1 MUMBAI, India and VANCOUVER, BC, Aug. 2, 2021 /PRNewswire/ -- Glenmark Pharmaceutic...

2021-08-02 18:45 2784

ElectroPhysiology Frontiers announces appointment of Avi Fischer, M.D. as CEO

MILAN, Aug. 2, 2021 /PRNewswire/ -- ElectroPhysiology Frontiers S.p.A. (EPF), announced that its Board of Directors unanimously appointedAvi Fischer, M.D. as Chief Executive Officer (CEO) of the company and a member of its Board of Directors. EPF is a medical technology company developing an inn...

2021-08-02 18:00 1772

Hummingbird Bioscience Announces UK MHRA Approval for First-in-Human Phase 1 Trial of HMBD-001 in Advanced Cancers

HOUSTON and SINGAPORE, Aug. 2, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

2021-08-02 17:00 1309

Envirotainer Welcomes China Southern Airlines as the first mainland China carrier to approve the Releye® RLP

STOCKHOLM, Aug. 2, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that China Southern Airlines has approved the Envirotainer Releye® RLP for usage on their fleet of aircrafts. With this approval...

2021-08-02 14:28 1555

Servier Announces Positive Topline Data from the Global Phase 3 Study of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia

TIBSOVO is the first targeted therapy to show improved event-free survival and overall survival in combination with azacitidine compared to azacitidine monotherapy. Safety profile consistent with previously published data in patients with IDH1-mutated acute myeloid leukemia. The study recently ...

2021-08-02 14:00 1920

Luye Pharma Enters Distribution Agreement with Zuellig Pharma for Seroquel and Seroquel XR in Malaysia and Brunei, Strengthening Business Presence in Asia Pacific and Improving Access to Evidence-Based Medical Treatments for Mental Health

SUBANG JAYA, Malaysia, Aug. 2, 2021 /PRNewswire/ -- Luye Pharma Group today announced that it has entered into an agreement with Zuellig Pharma, a leading healthcare service group inAsia, under which the company grants Zuellig Pharma exclusive rights to distribute its central nervous system drugs...

2021-08-02 10:25 3946

1 ... 303 304 305306307 308 309 ... 554